Onorato J M, Thorpe S R, Baynes J W
Department of Chemistry and Biochemistry, University of South Carolina, Columbia 29208, USA.
Ann N Y Acad Sci. 1998 Nov 20;854:277-90. doi: 10.1111/j.1749-6632.1998.tb09909.x.
Oxidative stress is apparent in pathology associated with aging and many age-related, chronic diseases, including atherosclerosis, diabetes mellitus, rheumatoid arthritis, and neurodegenerative diseases. Although it cannot be measured directly in biological systems, several biomarkers have been identified that provide a measure of oxidative damage to biomolecules. These include amino acid oxidation products (methionine sulfoxide, ortho-tyrosine (o-tyr) and dityrosine, chlorotyrosine and nitrotyrosine), as well as chemical modifications of protein following carbohydrate or lipid oxidation, such as N epsilon-(carboxymethyl)lysine and N epsilon-(carboxyethyl)lysine, and malondialdehyde and 4-hydroxynonenal adducts to amino acids. Other biomarkers include the amino acid cross-link pentosidine, the imidazolone adducts formed by reaction of 3-deoxyglucosone or methylglyoxal with arginine, and the imidazolium cross-links formed by the reaction of glyoxal and methylglyoxal with lysine residues in protein. These compounds have been measured in short-lived intracellular proteins, plasma proteins, long-lived extracellular proteins, and in urine, making them valuable tools for monitoring tissue-specific and systemic chemical and oxidative damage to proteins in biological systems. They are normally measured by sensitive high-performance liquid chromatography or gas chromatography-mass spectrometry methods, requiring both complex analytical instrumentation and derivatization procedures. However, sensitive immunohistochemical and ELISA assays are now available for many of these biomarkers. Immunochemical assays should facilitate studies on the role of oxidative stress in aging and chronic disease and simplify the evaluation of therapeutic approaches for limiting oxidative damage in tissues and treating pathologies associated with aging and disease. In this article we summarize recent data and conclusions based on immunohistochemical and ELISA assays, emphasizing the strengths and limitations of the techniques.
氧化应激在与衰老以及许多与年龄相关的慢性疾病相关的病理学中很明显,这些疾病包括动脉粥样硬化、糖尿病、类风湿性关节炎和神经退行性疾病。虽然它无法在生物系统中直接测量,但已鉴定出几种生物标志物,可用于衡量生物分子的氧化损伤。这些标志物包括氨基酸氧化产物(甲硫氨酸亚砜、邻酪氨酸(o-tyr)和二酪氨酸、氯酪氨酸和硝基酪氨酸),以及碳水化合物或脂质氧化后蛋白质的化学修饰,如Nε-(羧甲基)赖氨酸和Nε-(羧乙基)赖氨酸,还有丙二醛和4-羟基壬烯醛与氨基酸的加合物。其他生物标志物包括氨基酸交联物戊糖苷、3-脱氧葡萄糖醛酮或甲基乙二醛与精氨酸反应形成的咪唑酮加合物,以及乙二醛和甲基乙二醛与蛋白质中赖氨酸残基反应形成的咪唑鎓交联物。这些化合物已在短命的细胞内蛋白质、血浆蛋白质、长命的细胞外蛋白质以及尿液中进行了测量,使其成为监测生物系统中蛋白质的组织特异性和全身性化学及氧化损伤的宝贵工具。它们通常通过灵敏的高效液相色谱法或气相色谱-质谱法进行测量,这需要复杂的分析仪器和衍生化程序。然而,现在有许多针对这些生物标志物的灵敏免疫组织化学和酶联免疫吸附测定法。免疫化学测定法应有助于研究氧化应激在衰老和慢性疾病中的作用,并简化对限制组织氧化损伤和治疗与衰老及疾病相关病理学的治疗方法的评估。在本文中,我们总结了基于免疫组织化学和酶联免疫吸附测定法的最新数据和结论,强调了这些技术的优点和局限性。